Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is ...

Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $158 to $159 on April 17, ...

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Abbott Laboratories (NYSE:ABT) is one of the Best Dividend Stocks of 2025. In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers ...

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...

In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers, despite challenging conditions driven by tariffs.

Big bank earnings, June CPI inflation data, and U.S. retail sales, along with updates from TSMC, Netflix and Johnson & ...

Stocks are firmly higher this afternoon, with the Nasdaq and S&P 500 eyeing record closes after strong retail sales and jobs ...